TABLE 1.
Total number of consultations and HCV tests conducted during the pre and post‐COVID study periods across all included services
| Whole study period | Period 1 c, Pre‐lockdown period | Period 2, First/post‐first lockdown period | Period 3, Second lockdown period | Period 4, Post‐lockdowns | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Jan 2019–24 May 2021 | 1 January 2019–31 March 2020 | 1 April 2020–7 July 2020 | 8 July 2020–27 October 2020 | 28 October 2020–24 May 2021 | |||||||||||||
| Outcome | Outcome total | Number unique individuals | Outcome total | Number unique individuals | Weekly mean | Outcome total | Number unique individuals | Weekly mean | Relative change in weekly mean compared to period 1 | Outcome total | Number unique individuals | Weekly mean | Relative change in weekly mean compared to period 1 | Outcome total | Number unique individuals | Weekly mean | Relative change in weekly mean compared to period 1 |
| Antibody tests | 8748 | 7812 | 5237 | 4925 | 80.6 | 817 | 804 | 58.4 | −28% | 817 | 810 | 51.1 | −37% | 1877 | 1824 | 62.6 | −22% |
| RNA tests | 2403 | 2001 | 1673 | 1521 | 25.7 | 160 | 155 | 11.4 | −56% | 187 | 183 | 11.7 | −54% | 383 | 368 | 12.8 | −50% |
| First‐time testers | 5817 | 5817 | 3570 | 3570 | 54.9 | 536 | 536 | 38.3 | −30% | 527 | 527 | 32.9 | −40% | 1184 | 1184 | 39.5 | −28% |
| Consultations | 685,004 | 103,341 | 340,908 | 74,296 | 5244.7 | 78,558 | 36,959 | 5611.3 | 7% | 89,669 | 37,258 | 5604.3 | 7% | 175,869 | 53,846 | 5862.3 | 12% |